These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32026549)

  • 21. Cost-effective treatment modalities for reducing morbidity associated with chronic kidney disease.
    Ferguson TW; Tangri N; Rigatto C; Komenda P
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):243-52. PubMed ID: 25661187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Willingness to pay for kidney transplantation among chronic kidney disease patients in Ghana.
    Boima V; Agyabeng K; Ganu V; Dey D; Yorke E; Amissah-Arthur MB; Wilson AA; Yawson AE; Mate-Kole CC; Nonvignon J
    PLoS One; 2020; 15(12):e0244437. PubMed ID: 33378327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England.
    Nguyen NTQ; Cockwell P; Maxwell AP; Griffin M; O'Brien T; O'Neill C
    PLoS One; 2018; 13(11):e0207960. PubMed ID: 30475893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
    Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
    BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of health state utilities in breast cancer.
    Kim SH; Jo MW; Ock M; Lee HJ; Lee JW
    Patient Prefer Adherence; 2017; 11():531-536. PubMed ID: 28352159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Illness perceptions and treatment perceptions of patients with chronic kidney disease: different phases, different perceptions?
    Jansen DL; Heijmans MJ; Rijken M; Spreeuwenberg P; Grootendorst DC; Dekker FW; Boeschoten EW; Kaptein AA; Groenewegen PP
    Br J Health Psychol; 2013 May; 18(2):244-62. PubMed ID: 23126527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures.
    Small C; Kramer HJ; Griffin KA; Vellanki K; Leehey DJ; Bansal VK; Markossian TW
    BMC Nephrol; 2017 Jan; 18(1):3. PubMed ID: 28056852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis.
    Davies EW; Matza LS; Worth G; Feeny DH; Kostelec J; Soroka S; Mendelssohn D; McFarlane P; Belozeroff V
    Health Qual Life Outcomes; 2015 Jun; 13():90. PubMed ID: 26122041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic kidney disease in the Caribbean.
    Soyibo AK; Roberts L; Barton EN
    West Indian Med J; 2011 Jul; 60(4):464-70. PubMed ID: 22097679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue advanced glycation end product deposition after kidney transplantation.
    Crowley LE; Johnson CP; McIntyre N; Fluck RJ; McIntyre CW; Taal MW; Leung JC
    Nephron Clin Pract; 2013; 124(1-2):54-9. PubMed ID: 24135496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
    Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B;
    Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roads less traveled? Diverging research and clinical priorities for dialysis patients and those with less severe CKD.
    Tonelli M
    Am J Kidney Dis; 2014 Jan; 63(1):124-32. PubMed ID: 24252755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of health-related quality of life of chronic kidney disease patients in aminu kano teaching hospital, Kano.
    Ademola BL; Obiagwu PN; Aliyu A
    Niger J Clin Pract; 2020 Jul; 23(7):906-911. PubMed ID: 32620718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost of illness of chronic kidney disease in Lebanon: from the societal and third-party payer perspectives.
    Aoun M; Helou E; Sleilaty G; Zeenny RM; Chelala D
    BMC Health Serv Res; 2022 May; 22(1):586. PubMed ID: 35501814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness, cost effectiveness, acceptability and implementation barriers/enablers of chronic kidney disease management programs for Indigenous people in Australia, New Zealand and Canada: a systematic review of mixed evidence.
    Reilly R; Evans K; Gomersall J; Gorham G; Peters MD; Warren S; O'Shea R; Cass A; Brown A
    BMC Health Serv Res; 2016 Apr; 16():119. PubMed ID: 27048280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-analysis of persistent hyperkalaemia in non-dialysis chronic kidney disease patients under nephrology care in Italy.
    Provenzano M; De Francesco M; Iannazzo S; Garofalo C; Andreucci M; Genualdo R; Borrelli S; Minutolo R; Conte G; De Nicola L
    Int J Clin Pract; 2020 May; 74(5):e13475. PubMed ID: 31909866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme.
    Jha V; Al-Ghamdi SMG; Li G; Wu MS; Stafylas P; Retat L; Card-Gowers J; Barone S; Cabrera C; Garcia Sanchez JJ
    Adv Ther; 2023 Oct; 40(10):4405-4420. PubMed ID: 37493856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.